AXP

AXP Property Plant Equipment Net

$7.69BQuarterly · USD

Period ending:

AXP FY PP&E (Net)USD
AXP FY PP&E (Net)1989-12-31: $3.36B1990-12-31: $3.47B1991-12-31: $3.69B1992-12-31: $3.50B1993-12-31: $1.98B1994-12-31: $1.84B1995-12-31: $1.78B1996-12-31: $1.68B1997-12-31: $1.53B1998-12-31: $1.64B1999-12-31: $2.00B2000-12-31: $2.51B2001-12-31: $2.81B2002-12-31: $2.98B2003-12-31: $3.18B2004-12-31: $2.38B2005-12-31: $2.23B2006-12-31: $2.35B2007-12-31: $2.69B2008-12-31: $2.95B2009-12-31: $2.78B2010-12-31: $2.91B2011-12-31: $3.37B2012-12-31: $3.64B2013-12-31: $3.88B2014-12-31: $3.94B2015-12-31: $4.11B2016-12-31: $4.43B2017-12-31: $4.33B2018-12-31: $4.42B2019-12-31: $4.83B2020-12-31: $5.02B2021-12-31: $4.99B2022-12-31: $5.22B2023-12-31: $5.91B2024-12-31: $6.18B2025-12-31: $7.12B$7.12B$0.00
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AXP property plant equipment net history

Net property, plant, and equipment. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

American Express Property Plant Equipment Net — Annual fiscal periods (USD)
Period endingProperty Plant Equipment Net (USD)
7,116,000,000
6,175,000,000
5,908,000,000
5,215,000,000
4,988,000,000
5,015,000,000
4,834,000,000
4,416,000,000
4,329,000,000
4,433,000,000
4,108,000,000
3,938,000,000
3,875,000,000
3,635,000,000
3,367,000,000
2,905,000,000
2,782,000,000
2,948,000,000
2,692,000,000
2,350,000,000
2,230,000,000
2,380,000,000
3,184,000,000
2,979,000,000
2,811,000,000
2,506,000,000
1,996,000,000
1,637,000,000
1,533,000,000
1,675,000,000
1,783,000,000
1,840,000,000
1,976,000,000
3,497,000,000
3,688,000,000
3,466,000,000
3,357,000,000

Compare property plant equipment net

All AXP financial metrics · AXP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.